Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Onze Lieve Vrouwziekenhuis
Aalst, Belgium
- Zna Middelheim
Antwerp, Belgium
- Az St- Lucas
Bruges, Belgium
- Cliniques Universitaires St Luc
Brussels, Belgium
- Erasme Hospital
Brussels, Belgium
- Az Groeninge
Kortrijk, Belgium
- C.H.U. Sart-Tilman
Liège, Belgium
- Clinique Sainte Elisabeth
Namur, Belgium
- H. Hartziekenhuis
Roeselare, Belgium
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Mar 2014
- Completion
- 31 Mar 2019
- Last update posted
- 10 Jul 2019
- Registered enrollment
- 84
- Registry id
- NCT00828672
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.